Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
25,296,136
-
Total 13F shares
-
38,938
-
Share change
-
+38,938
-
Total reported value
-
$90,552
-
Price per share
-
$2.33
-
Number of holders
-
9
-
Value change
-
+$90,552
-
Number of buys
-
9
Institutional Holders of Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (PTPI) as of Q4 2022
As of 31 Dec 2022 Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (PTPI) had 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 38,938 shares of stock of the company.
Largest 9 holders included VANGUARD GROUP INC, BlackRock Inc., UBS Group AG, EMFO, LLC, Tower Research Capital LLC (TRC), MORGAN STANLEY, FIRST MANHATTAN CO, WELLS FARGO & COMPANY/MN, and BANK OF AMERICA CORP /DE/.
This table shows 9 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.